Anales de la RANM

133 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 HIPOTENSIÓN EN HIPERTENSOS MAYORES TRATADOS Banegas JR An RANM. 2022;139(02): 128 - 134 6. Williams B, Mancia G, Spiering W, et al; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hy- pertension. Eur Heart J. 2018;39:3021-3104. doi: 10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019;40(5):475. PMID: 30165516. 7. Visseren FLJ, Mach F, Smulders YM, et al; ESC National Cardiac Societies; ESC Scienti- fic Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227-3337. doi: 10.1093/eurheartj/ehab484. 8. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective in- terventions for elevated blood pressure and hy- pertension. Nat Rev Cardiol. 2021;18:785-802. 9. Chow CK, Teo KK, Rangarajan S, et al; PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-inco- me countries. JAMA. 2013;310(9):959-968. doi: 10.1001/jama.2013.184182. 10. Banegas JR, de la Cruz JJ, Graciani A, et al. Im- pact of Ambulatory Blood Pressure Monitoring on Reclassification of Hypertension Prevalen- ce and Control in Older People in Spain. J Clin Hypertens (Greenwich). 2015;17(6):453-461. doi: 10.1111/jch.12525. Epub 2015 Mar 16. PMID: 25779903. 11. Stergiou GS, Palatini P, Parati G, et al; Euro- pean Society of Hypertension Council and the European Society of Hypertension Working Group on Blood Pressure Monitoring and Car- diovascular Variability. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39:1293-1302. doi: 10.1097/ HJH.0000000000002843. 12. Gijón-Conde T, Gorostidi M, Banegas JR, et al. Documento de la Sociedad Española de Hi- pertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre monitorización ambulatoria de la presión ar- terial (MAPA) 2019. Hipertens Riesgo Vasc. 2019;36:199-212. 13. Yang WY, Melgarejo JD, Thijs L, et al; Inter- national Database on Ambulatory Blood Pres- sure in Relation to Cardiovascular Outco- mes (IDACO) Investigators. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Out-comes. JAMA. 2019;322(5):409-420. doi: 10.1001/ jama.2019.9811. 14. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Ma- nagement of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Asso- ciation Task Force on Clinical Practice Gui- delines. Hypertension. 2018 ;71(6):1269-1324. doi: 10.1161/HYP.0000000000000066. Epub 2017 Nov 13. Erratum in: Hypertension. 2018 Jun;71(6):e136-e139. Erratum in: Hypertension. 2018 Sep;72(3):e33. PMID: 29133354. 15. Unger T, Borghi C, Charchar F, et al. 2020 In- ternational Society of Hypertension Global Hypertension Practice Guidelines. Hyperten- sion. 2020;75:1334-1357. doi: 10.1161/HY- PERTENSIONAHA.120.15026. 16. National Institute for Health and Clinical Excellence (NICE). Hypertension in adults: diagnosis and management. NICE guideline [NG136] Published: 28 August 2019 Last up- dated: 18 March 2022. www.nice.org.uk/gui- dance/ng136 Accessed 26 may 2022. 17. Orozco-Beltrán D, Brotons-Cuixart C, Bane- gas JR, et al. Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022. Aten Primaria. 2022 (en prensa). 18. Gilani A, Juraschek SP, Belanger MJ, Vowles JE, Wannamethee SG. Postural hypotension. BMJ 2021;373:n922. http://dx.doi.org/10.1136/bmj.n922 19. O'Brien E, Parati G, Stergiou G, et al, Euro- pean Society of Hypertension Working Group on Blood Pressure Monitoring European So- ciety of Hypertension position paper on am- bulatory blood pressure monitoring. J Hyper- tens. 2013;31(9):1731-1768. 18doi: 10.1097/ HJH.0b013e328363e964. 20. O’Brien E, Kario K, Staessen JA, de la Sierra A, Ohkubo T. Patterns of ambulatory blood pres- sure: clinical relevance and application. J Clin Hypertens. 2018;20:1112-1115. 21. Gracia Guillén, D. Primum non nocere. El principio de no-maleficencia como funda- mento de la ética médica; con contestación del Excmo Sr. D. Pedro Laín Entralgo (3 de abril de 1990). Instituto de España, Real Academia Nacional de Medicina. Madrid, 1990. 22. SPRINT Research Group; Lewis CE, Fine LJ, Beddhu S, et al. Final Report of a Trial of In- tensive versus Standard Blood-Pressure Con- trol. N Engl J Med. 2021;384(20):1921-1930. doi: 10.1056/NEJMoa1901281. 23. Ruiz-Hurtado G, Banegas JR, Sarafidis PA, Vol- pe M, Williams B, Ruilope LM. Has the SPRINT trial introduced a new blood-pressure goal in hypertension? Nat Rev Cardiol. 2017;14(9):560- 566. doi: 10.1038/nrcardio.2017.74. 24. Lonn E, Bosch J, López-Jaramillo P, et al. Blood-Pressure Lowering in Intermediate- Risk Persons without Cardiovascular Disease. N Engl J Med. 2016;374(21):2009-2020. doi: 10.1056/NEJMoa1600175. . 25. Zhang W, Zhang S, Deng Y, et al; STEP Stu- dy Group. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N Engl J Med. 2021;385(14):1268-1279. doi: 10.1056/NEJMoa2111437 26. Arguedas JA, Leiva V, Wright JM. Blood pressure targets in adults with hyperten- sion. Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD004349. doi: 10.1002/14651858. CD004349.pub3. 27. Böhm M, Schumacher H, Teo KK, et al. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk pa- tients: results from ONTARGET and TRANS- CEND trials. Eur Heart J. 2018;39(33):3105- 3114. doi: 10.1093/eurheartj/ehy287.